Laparoscopic Ultra-radical Lymph Node Debulking Using Yasargil Clamps (Yasargil-1)
- Conditions
- Gynecologic Cancer
- Interventions
- Procedure: Laparoscopic ultra-radical lymph node debulking
- Registration Number
- NCT05318170
- Lead Sponsor
- University of Palermo
- Brief Summary
Although several studies have demonstrated the overall benefits of a laparoscopic approach for pelvic and para-aortic lymphadenectomy, complications remain a challenging scenario. Vascular injury occurs in 0.3% to 1.0% of laparoscopic procedures, with potentially lethal consequences. Vascular injuries are usually managed using coagulation, clamps or vascular sutures, but if these measures fail, laparotomy is inevitable.
To date, few reports evaluated the use of minimally invasive surgery for lymph node debulking in gynecological cancer patients with metastatic bulky lymph nodes, with encouraging results, despite the small sample sizes. Nevertheless, new minimally invasive surgery techniques that may minimize intraoperative complications are necessary. Considering these elements, this multicenter retrospective analysis is aimed to evaluate intra- and post-operative surgical outcomes, after laparoscopic ultraradical lymph nodal debulking using Yasargil clamps in gynecological cancer patients with bulky lymph node metastases.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 43
- At least one bulky lymph node with size ≥ 25 mm
- Age > 18 years
- Body mass index (BMI) < 40 kg/m²
- Absence of abdominal adhesion syndrome and intraperitoneal dissemination at the time of laparoscopic evaluation
- Disease-free interval < 6 months and/or
- Performance status > 2 according to Eastern Cooperative Oncology Group (ECOG) criteria
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Women affected by gynecological cancer Laparoscopic ultra-radical lymph node debulking Women affected by gynecological cancer (cervical, endometrial, ovarian and vulvar cancer)
- Primary Outcome Measures
Name Time Method Complications During the surgery and within 30 days after the surgery Any complication occurred
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Palermo
🇮🇹Palermo, Sicily, Italy